NCT05157542 2021-12-15
Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC
Sichuan Cancer Hospital and Research Institute
Phase 1 Unknown
Clinical Trials
7 trialsNCT04405674 2021-11-22
Tislelizumab Combined With Chemotherapy With or Without Bevacizumab in TKI-Resistant EGFR-Mutated Non-squamous NSCLC
Shanghai Chest Hospital
Phase 2 Unknown
NCT01711697 2021-06-23
An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Emory University
Phase 1 Unknown
NCT04094909 2020-02-07
Rh-endostatin Combined With Chemotherapy and Pembrolizumab for Advanced NSCLC
Guangzhou Institute of Respiratory Disease
Phase 2 Unknown
NCT02734524 2018-01-23
A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer
Southwest Hospital, China
Phase 2 Unknown
NCT02016209 2013-12-19
Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer
Zhejiang University
Phase 2 Unknown
NCT01872403 2013-06-07
Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage â…¡ B and IIIA Squamous Cell Carcinoma of the Lung
The First Affiliated Hospital of Guangzhou Medical University
Phase 2 Unknown